产品中心 抗体 其他一抗

所有图片(1/2)

Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb (S-1146-117)

Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1,EBP-1,Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B1284
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    Phospho-NF-κB p105 (Ser932)
  • 分子别名

    Nuclear factor NF-kappa-B p105 subunit; DNA-binding factor KBF1; EBP-1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm, Nucleus
  • Accession

    P19838
  • 克隆号

    S-1146-117
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 翻译后修饰类型

    磷酸化
  • 反应种属 ?

    Ms, Rt
  • 预测反应种属
    (反应种属缩写表)

    Dg
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Ms, Rt
背景介绍
  • Phospho-NF-κB p105 (Ser932) refers to the phosphorylated form of the NF-κB p105 protein at the serine residue 932. This post-translational modification is significant as it triggers a series of events that lead to the activation of the NF-κB signaling pathway, which is crucial in regulating immune and inflammatory responses. When p105 is phosphorylated at Ser932 by the IKK complex, it recruits the SCFβTrCP E3 ligase, leading to the ubiquitination and subsequent proteasomal degradation of p105. This degradation releases the active form of TPL-2, which in turn activates the MEK/ERK signaling pathway. Therefore, phosphorylation at Ser932 is a key regulatory step in controlling NF-κB activation and MAP kinase signaling, which coordinate the functions of lymphocytes and macrophages in the immune response.

  • 免疫印迹

    • WB result of Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb
      Primary antibody: Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated NIH/3T3 whole cell lysate 20 µg
      Lane 2: NIH/3T3 treated with 20 ng/ml TNF-α for 10 minutes and 100 nM Calyculin A for 10 minutes whole cell lysate 20 µg
      Lane 3: NIH/3T3 treated with 20 ng/ml TNF-α for 10 minutes and 100 nM Calyculin A for 10 minutes, then treated with phosphatase whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 105 kDa
      Observed MW: 110 kDa

    • WB result of Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb
      Primary antibody: Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated C6 whole cell lysate 20 µg
      Lane 2: C6 treated with 100 nM Calyculin A for 30 minutes whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 105 kDa
      Observed MW: 110 kDa

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

检测磷酸化蛋白时,推荐有什么封闭体系?

我们推荐客户使用TPST+5%脱脂奶粉来稀释一抗,进行封闭。 虽然BSA被推荐为WB检测磷酸化蛋白的常用封闭剂,但是脱脂奶粉获取更加方便,覆盖更广泛的非特异性结合位点,在一抗性能优越的前提下,使用脱脂奶粉封闭性价比更高

评论(0)